THE IMPACT OF SIROLIMUS-RELATED PROTEINURIA ON PROGRESSION OF CARDIAC ALLOGRAFT VASCULOPATHY AND OUTCOMES AMONG HEART TRANSPLANT RECIPIENTS

Rabea Asleh; Hilmi Alnsasra; Amir Lerman; Alexandros Briasoulis; Naveen L. Pereira; Brooks S. Edwards; John M. Stulak; Alfredo L. Clavell; Richard C. Daly; Sudhir S. Kushwaha

doi:https://doi.org/10.1016/s0735-1097(20)31700-9

doi.org/10.1016/s0735-1097(20)31700-9

THE IMPACT OF SIROLIMUS-RELATED PROTEINURIA ON PROGRESSION OF CARDIAC ALLOGRAFT VASCULOPATHY AND OUTCOMES AMONG HEART TRANSPLANT RECIPIENTS

,

,

..., Sudhir S. Kushwaha

42

Journal of the American College of Cardiology24.00

Volume: 75, Issue: 11, Pages: 1073 - 1073

Published: Mar 1, 2020

Abstract

We have previously described the use of sirolimus (SRL) as primary immunosuppression therapy following heart transplantation (HT). The advantages of this approach include attenuation of cardiac allograft vasculopathy (CAV), improvement in glomerular filtration rate (GFR) and a decrease in rates...

Paper Fields

Paper Details

Title

THE IMPACT OF SIROLIMUS-RELATED PROTEINURIA ON PROGRESSION OF CARDIAC ALLOGRAFT VASCULOPATHY AND OUTCOMES AMONG HEART TRANSPLANT RECIPIENTS

DOI

doi.org/10.1016/s0735-1097(20)31700-9

Published Date

Mar 1, 2020

Journal

Journal of the American College of Cardiology

Volume

75

Issue

11

Pages

1073 - 1073

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History